Antidote raises USD23m to scale digital patient engagement services
Antidote Technologies Limited (Antidote) has closed USD23.2 million in funding to expand its digital patient engagement programs and clinical trial recruitment services. The funding round was led by LBO France, a private equity firm committed to supporting the growth of digital health, both in transforming health systems and accelerating medical
